Ridgeback Capital Investments’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-68,333	Closed	-$24.8M	–	2
2013 Q4	$24.8M	Buy	+68,333	New	+$24.8M	31.36%	2